[Commentary on] Parity, oral contraceptives, and the risk ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation Journal Article

  


Author: Boyd, J.
Article Title: [Commentary on] Parity, oral contraceptives, and the risk ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation
Keywords: mutation; chemoprevention; parity; ovarian neoplasms -- familial and genetic; ovarian neoplasms -- risk factors; female; contraceptives, oral -- adverse effects
Journal Title: Women's Oncology Review
Volume: 1
Issue: 4
ISSN: 1473-3404
Publisher: Taylor & Francis Group  
Date Published: 2001-12-01
Start Page: 400
End Page: 401
Language: English
ACCESSION: 2004132016
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:

http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=2004132016&site=ehost-live
Notes: Accession Number: 2004132016 -- Entry Date: 20040806 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U et al -- Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation -- N ENGL J MED 2001 Jul 26; 345(4): 235-40 (research) -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20